Literature DB >> 8792484

The impact of Haemophilus influenzae type b vaccination in Sweden.

O Garpenholt1, S A Silfverdal, S Hugosson, H Fredlund, L Bodin, V Romanus, P Olcén.   

Abstract

The number of patients with meningitis and bacteremia due to Haemophilus influenzae was studied in Sweden over the period 1987-1994. Conjugated H. influenzae type b vaccines were introduced in Sweden in 1992, and all children born after December 31, 1992, were offered vaccination free of charge. A rapid decline of H. influenzae meningitis and bacteraemia was observed in the autumn of 1993, when the expected peak incidence failed to appear. In the prevaccination period 1987-1991, the average annual incidence (cases/100,000) was 34.4 in children aged 0-4 years. In 1994, the annual incidence fell to 3.5. No significant decline was observed in older children or adults. There was a 92% reduction in the number of meningitis cases and an 83% reduction in cases of bacteraemia. A similar decline was noted in 2 regions which followed different strategies for the introduction of the vaccination programme.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8792484     DOI: 10.3109/00365549609049069

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  9 in total

Review 1.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  Cloning of genes of nontypeable Haemophilus influenzae involved in penetration between human lung epithelial cells.

Authors:  M van Schilfgaarde; P van Ulsen; W van Der Steeg; V Winter; P Eijk; V Everts; J Dankert; L van Alphen
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

Review 3.  Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates.

Authors:  H Peltola
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

4.  Changes in ascertainment of Hib and its influence on the estimation of disease incidence in the United Kingdom.

Authors:  S Ladhani; M P Slack; P T Heath; M E Ramsay
Journal:  Epidemiol Infect       Date:  2006-11-09       Impact factor: 2.451

5.  Bacterial meningitis: epidemiology, pathogenesis and management update.

Authors:  Yuliya Nudelman; Allan R Tunkel
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 6.  Bacterial meningitis: the impact of vaccination.

Authors:  Nick Makwana; F Andrew I Riordan
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

7.  Bacterial meningitis: Aetiology, risk factors, disease trends and severe sequelae during 50 years in Sweden.

Authors:  Nils Block; Pontus Naucler; Philippe Wagner; Eva Morfeldt; Birgitta Henriques-Normark
Journal:  J Intern Med       Date:  2022-04-03       Impact factor: 13.068

8.  Invasive Haemophilus influenzae infections in Germany: impact of non-type b serotypes in the post-vaccine era.

Authors:  Helen Kalies; Anette Siedler; Britta Gröndahl; Veit Grote; Astrid Milde-Busch; Rüdiger von Kries
Journal:  BMC Infect Dis       Date:  2009-04-20       Impact factor: 3.090

9.  Mortality in Children Aged 0-9 Years: A Nationwide Cohort Study from Three Nordic Countries.

Authors:  Yongfu Yu; Guoyou Qin; Sven Cnattingius; Mika Gissler; Jørn Olsen; Naiqing Zhao; Jiong Li
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.